HF
NVCR icon

HRT Financial’s NovoCure NVCR Stock Holding History

HRT Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-250,862
Closed -$3.24M – 4432
2025
Q4 		$3.24M Sell
250,862
-112,676
-31% -$1.45M 0.01% 1000
2025
Q3 		$4.7M Buy
363,538
+312,328
+610% +$4.17M 0.02% 697
2025
Q2 		$911K Buy
+51,210
New +$892K ﹤0.01% 1309
2024
Q2 		– Sell
-88,730
Closed -$1.39M – 2826
2024
Q1 		$1.39M Sell
88,730
-88,121
-50% -$1.3M 0.01% 728
2023
Q4 		$2.64M Buy
176,851
+140,998
+393% +$1.89M 0.02% 535
2023
Q3 		$579K Buy
+35,853
New +$1.03M 0.01% 1327
2022
Q4 		– Sell
-25,908
Closed -$1.97M – 2929
2022
Q3 		$1.97M Buy
25,908
+21,723
+519% +$1.69M 0.02% 605
2022
Q2 		$290K Buy
+4,185
New +$315K ﹤0.01% 2045
2022
Q1 		– Sell
-28,671
Closed -$2.15M – 3626
2021
Q4 		$2.15M Sell
28,671
-20,055
-41% -$2.01M 0.01% 619
2021
Q3 		$5.66M Buy
+48,726
New +$7.37M 0.03% 289
2020
Q3 		– Sell
-49,088
Closed -$2.91M – 2219
2020
Q2 		$2.91M Buy
49,088
+42,509
+646% +$2.8M 0.09% 248
2020
Q1 		$443K Buy
+6,579
New +$520K 0.03% 418
2019
Q4 		– Sell
-19,436
Closed -$1.45M – 1490
2019
Q3 		$1.45M Buy
+19,436
New +$1.55M 0.07% 250

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

HRT Financial's NVCR Position: Q1 2026 in Review

HRT Financial sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 250,862 shares — an estimated $3.24M sold.

HRT Financial first reported a position in NVCR in Q3 2019 and held it in 13 quarters. The position peaked at $5.66M in Q3 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • HRT Financial reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 250,862 NovoCure shares in Q1 2026, an estimated $3.24M.
  • HRT Financial first reported a position in NovoCure in Q3 2019 and held it in 13 quarters.
  • HRT Financial's NovoCure position peaked at $5.66M in Q3 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.